21-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1140 18 939 90 1096 169 1029
ERLYTX 74 2 104 7 85 8 49
GI 163 4 209 15 183 28 170
GU 403 10 522 57 694 93 566
LEUK 163 1 52 14 170 28 170
LUNG 211 7 365 19 231 29 177
LYMPH 428 7 365 35 426 65 396
MELAN 8 0 0 1 12 1 6
MMYEL 115 1 52 13 158 21 128
MULT 47 0 0 2 24 3 18
OTHER 44 0 0 2 24 2 12
Total 2796 50 2608 255 3103 447 2721

21-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 217 4 209 20 244 39 237
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 0 0
GU 6 1 52 2 24 4 24
LEUK 621 14 730 61 743 108 657
LUNG 371 8 417 44 536 64 390
LYMPH 1 0 0 1 12 1 6
OTHER 17 2 104 2 24 5 30
PEOLC 59 0 0 3 37 3 18
PREV 228 2 104 19 231 28 170
SXQOL 658 13 678 53 645 99 603
Total 2181 44 2294 205 2496 351 2135

21-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1140 18 939 90 1096 169 1029
CCD 217 4 209 20 244 39 237
ERLYTX 76 2 104 7 85 8 49
GI 164 4 209 15 183 28 170
GU 409 11 574 59 718 97 590
LEUK 784 15 783 75 913 136 828
LUNG 582 15 783 63 767 93 566
LYMPH 429 7 365 36 438 66 402
MELAN 8 0 0 1 12 1 6
MMYEL 115 1 52 13 158 21 128
MULT 47 0 0 2 24 3 18
OTHER 61 2 104 4 49 7 43
PEOLC 59 0 0 3 37 3 18
PREV 228 2 104 19 231 28 170
SXQOL 658 13 678 53 645 99 603
Total 4977 94 4904 460 5600 798 4857

21-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 700 12 626 59 718 99 603
ERLYTX 54 2 104 7 85 7 43
GI 126 3 157 10 122 22 134
GU 294 7 365 38 463 63 384
LEUK 101 0 0 6 73 13 79
LUNG 135 6 313 13 158 22 134
LYMPH 281 5 261 23 280 41 250
MELAN 8 0 0 1 12 1 6
MMYEL 65 0 0 9 110 12 73
MULT 19 0 0 2 24 2 12
OTHER 44 0 0 2 24 2 12
Total 1827 35 1826 170 2069 284 1730

21-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 159 3 157 12 146 28 170
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 0 0
GU 6 1 52 2 24 4 24
LEUK 251 5 261 23 280 37 225
LUNG 229 7 365 31 377 46 280
LYMPH 1 0 0 1 12 1 6
OTHER 17 2 104 2 24 5 30
PEOLC 50 0 0 3 37 3 18
PREV 228 2 104 19 231 28 170
SXQOL 479 10 522 41 499 71 432
Total 1423 30 1565 134 1630 223 1355

21-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 898 16 835 80 974 141 858
CCD 172 3 157 11 134 23 140
ERLYTX 56 2 104 7 85 7 43
GI 140 3 157 13 158 29 177
GU 331 6 313 38 463 65 396
LEUK 355 5 261 29 353 50 304
LUNG 396 15 783 46 560 77 469
LYMPH 282 5 261 24 292 42 256
MELAN 8 0 0 1 12 1 6
MMYEL 65 0 0 9 110 12 73
MULT 42 0 0 4 49 8 49
OTHER 126 2 104 4 49 7 43
PEOLC 52 1 52 3 37 4 24
PREV 228 2 104 19 231 28 170
SXQOL 479 10 522 41 499 71 432
Total 3630 70 3653 329 4006 565 3440

21-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 987 17 887 85 1035 160 974
ERLYTX 70 1 52 6 73 7 43
GI 96 3 157 10 122 17 103
GU 295 8 417 47 572 69 420
LEUK 134 1 52 14 170 26 158
LUNG 185 6 313 16 195 25 152
LYMPH 355 7 365 34 414 60 365
MMYEL 102 1 52 12 146 20 122
MULT 47 0 0 2 24 3 18
Total 2271 44 2295 226 2751 387 2355

21-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1900 37 1931 175 2131 294 1790
AFFIL 122 1 52 5 61 8 49
CCOP/NCORP 1228 27 1409 124 1510 205 1248
Non-SWOG 1722 24 1252 151 1838 286 1741
Total 4972 89 4644 455 5540 793 4828

21-OCT-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK S2507 ALL/ALAL, KMT2A-trans, Blina +/- Revumenib 1 Y 22-SEP-26

21-OCT-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
OTHER NRGGY026 Endomet, Stage I-IV, Pac/Car w/ HER HYL/PHE 1 E 29-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 1 E 28-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 2 E 28-SEP-26
SXQOL NRG-CC013 HN Squamous Cell, Rec Chemo, BMX 1 E 23-SEP-26
LUNG S1900J MET Amplification: Amivantamab Hyaluronidase 1 N 15-OCT-26
OTHER NRGHN009 HN, RT + HD Cisp vs RT + LD Cisp for SCCHN 1 E 02-OCT-26

21-OCT-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 14
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 14
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 10
LUNG LUNGMAP NSCLC, Adv, Master 1 7
LUNG LUNGMAP NSCLC, Adv, Master 2 6
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 6
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 3 5
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 4
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 4
SXQOL NRGCC015 E-Mindfulness After Breast Cancer 1 3
LUNG S1800E Non-Match: Docetaxel + Ramu +/- Cemiplimab 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3
GI S2303 Gas/Esoph/GEJ, Adv, Ram + Pac +/- Nivo 1 3
LUNG S2409 ESCLC, Durvalumab +/- Biomarker Directed Tx 1 3